Risk of Covid-19-Related Hospitalization and More Severe Outcomes in Medicare Beneficiaries Treated with Renin-Angiotensin-Aldosterone System Inhibitors for Hypertension-Reference-Cited by-同舟云学术

Risk of Covid-19-Related Hospitalization and More Severe Outcomes in Medicare Beneficiaries Treated with Renin-Angiotensin-Aldosterone System Inhibitors for Hypertension

Published:2021-10-01 Issue:12 Volume:36 Page:3802-3809
ISSN:0884-8734
Container-title:Journal of General Internal Medicine
language:en
Short-container-title:J GEN INTERN MED

Author:

Graham David J.^ORCID,Izurieta Hector S.,Muthuri Stella G.,Zhang Di,Sandhu Alexander T.,Lu Yun,Zhao Yueqin,Feng Yuhui,Eworuke Efe,Lyu Hai,Gandotra Charu,Smith Elizabeth R.,Avagyan Armen,Wernecke Michael,Kelman Jeffrey A.,Forshee Richard A.,MaCurdy Thomas E.

Funder

U.S. Food and Drug Administration

Publisher

Springer Science and Business Media LLC

Subject

Internal Medicine

Link

https://link.springer.com/content/pdf/10.1007/s11606-021-07155-z.pdf

Reference33 articles.

1. Hoffmann M, Kleine-Weber H, Schroeder S, et al. SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell. 2020;181(2):271-280.e8.

2. Bavishi C, Maddox TM, Messerli FH. Coronavirus disease 2019 (Covid-19) infection and the renin angiotensin system blockers. JAMA Cardiol. 2020;5(7):745-747.

3. Tikellis C, Thomas MC. Angiotensin-converting enzyme 2 (ACE2) is a key modulator of the renin angiotensin system in health and disease. Int J Pept. 2012;2012:256-294.

4. Vaduganthan M, Vardeny O, Michel T, McMurray JJV, Pfeffer MA, Solomon SD. Renin-angiotensin-aldosterone system inhibitors in patients with Covid-19. N Engl J Med. 2020;382(17):1653-1659.

5. Hales CM, Servais J, Martin CB, Kohen D. Prescription drug use among adults aged 40-79 in the United States and Canada. NCHS Data Brief. 2019;347:1-8.

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Association of Cardiovascular Medications With Adverse Outcomes in a Matched Analysis of a National Cohort of Patients With COVID-19;American Journal of Medicine Open;2023-06

2. Uso previo de antagonistas de la angiotensina II en pacientes hipertensos hospitalizados y mortalidad por COVID-19;Revista del Cuerpo Médico Hospital Nacional Almanzor Aguinaga Asenjo;2022-09-24

3. Renin‐Angiotensin Aldosterone System Inhibitors and COVID‐19: A Systematic Review and Meta‐Analysis Revealing Critical Bias Across a Body of Observational Research;Journal of the American Heart Association;2022-06-07